Simotinib hydrochloride

Simotinib hydrochloride is a potent and selective oral EGFR tyrosine kinase inhibitor with an IC50 of 19.9 nM. It demonstrates significant antitumor activity in vitro and has shown efficacy in preclinical in vivo models of EGFR-driven cancers.